NeuropaceNPCE

13F holders, Q2 2024 (June 30)
51holders −3
17new positions
21sold out
3famous investors
$7.56avg. 13F price*

At the end of Q2 2024, 51 institutions reported holding Neuropace Inc. (NPCE) in their 13F filings, down 3 from Q1 2024. 17 opened new positions and 21 sold out. The largest holders were Orbimed Advisors LLC ($25.8M), Morgan Stanley ($18.7M) and Soleus Capital Management, L.P. ($18.4M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Neuropace Inc.
CUSIP
641288105
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 54Q1 2024Q2 2024: 51Q2 2024Q3 2024: 48Q3 2024Q4 2024: 62Q4 2024Q1 2025: 90Q1 2025Q2 2025: 98Q2 2025Q3 2025: 80Q3 2025Q4 2025: 100Q4 2025Q1 2026: 113Q1 2026Q2 2026: 112Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions17$6.5M
Exits21$8.3M

All 13F filers, Q1 2024 → Q2 2024: 2,891,328 shares bought and 1,834,241 shares sold, net +1,057,087 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 51 holders

Orbimed Advisors LLC 0.51% Reduce -14.9% 3,406,335 $25.8M
Morgan Stanley 0.00% Reduce -0.5% 2,471,142 $18.7M
Soleus Capital Management, L.P. 1.62% No change 2,433,168 $18.4M
Kent Lake Capital LLC 3.90% Add +77.8% 1,144,254 $8.7M
Vanguard Group Inc. 0.00% Add +98.0% 967,716 $7.3M
Millennium Management 0.00% Add +13.3% 686,037 $5.2M
BlackRock Inc. 0.00% Add +804.7% 670,875 $5.1M
Deutsche Bank AG 0.00% New 653,685 $4.9M
Nantahala Capital Management, LLC 0.47% Reduce -20.7% 616,823 $4.7M
Geode Capital Management, LLC 0.00% Add +149.5% 291,862 $2.2M
FMR LLC 0.00% Reduce -17.6% 249,394 $1.9M
State Street Corp. 0.00% Add +282.8% 142,578 $1.1M
Renaissance Technologies 0.00% Reduce -32.3% 81,200 $614K
Acadian Asset Management LLC 0.00% Add +46.0% 68,918 $520K
Northern Trust Corp. 0.00% Add +42.5% 42,165 $319K
Man Group plc 0.00% Add +1.4% 38,470 $291K
Citadel Advisors 0.00% Add +355.4% 37,112 $281K
Charles Schwab Investment Management Inc. 0.00% New 36,537 $276K
Bank of New York Mellon Corp 0.00% New 34,059 $257K
Bridgeway Capital Management, LLC 0.01% No change 33,200 $251K
Two Sigma Investments, LP 0.00% New 33,094 $250K
Bank of Montreal 0.00% New 32,223 $246K
Marshall Wace, LLP 0.00% Reduce -45.1% 32,045 $242K
XTX Topco Ltd 0.02% Add +56.1% 24,055 $182K
Goldman Sachs Group Inc. 0.00% Reduce -82.9% 23,948 $181K
Nuveen Asset Management, LLC 0.00% New 18,420 $139K
Bank of America Corp. 0.00% Add +26.4% 17,318 $131K
Financial Advocates Investment Management 0.01% Add +50.0% 15,000 $113K
Rhumbline Advisers 0.00% New 14,664 $111K
New York State Common Retirement Fund 0.00% New 14,300 $108K
Alpine Global Management, LLC 0.02% New 12,923 $98K
Cubist Systematic Strategies, LLC 0.00% Reduce -77.3% 11,519 $87K
Jump Financial, LLC 0.00% Reduce -55.2% 11,431 $86K
Mitsubishi UFJ Asset Management Co., Ltd. 0.00% New 9,108 $69K
Qube Research & Technologies Ltd 0.00% Reduce -80.5% 8,833 $67K
Corebridge Financial, Inc. 0.00% — 7,343 $56K
Wells Fargo & Company 0.00% Add +206.0% 6,370 $48K
JPMorgan Chase & Co. 0.00% Reduce -81.9% 5,816 $44K
Barclays PLC 0.00% Reduce -66.7% 4,626 $35K
Tower Research Capital LLC (TRC) 0.00% Add +17.2% 4,411 $33K
UBS Group AG 0.00% Add +141.4% 4,104 $31K
Lazard Asset Management LLC 0.00% Reduce -3.3% 3,426 $25K
Citigroup Inc. 0.00% Reduce -96.1% 2,969 $22K
Legal & General Group Plc 0.00% New 1,508 $11K
Ameritas Investment Partners, Inc. 0.00% New 1,337 $10K
Royal Bank of Canada 0.00% New 1,283 $10K
Jones Financial Companies LLLP 0.00% New 1,000 $8K
California State Teachers Retirement System 0.00% New 989 $7K
Amalgamated Bank 0.00% New 472 $4K
Simplex Trading, LLC 0.00% New 370 $2K
Cwm, LLC 0.00% No change 166 $1K

"% of holder's portfolio" is NPCE's weight in each manager's 13F, not the share of Neuropace Inc. the manager owns.